Recipient of federal assistance · SAN DIEGO, CA

MODULO BIO, INC.

MODULO BIO, INC. received $4.1M in federal grants and other assistance in FY2026, on 5 actions. It has no federal contracts in the loaded years. Since FY2023: $7M. Its largest awarding agency was National Institutes of Health ($2.3M).

Assistance · FY2026
$4.1M
New awards
3
Actions
5
Since FY2023
$7M
UEI
U1TNJGPGNHA9
Location
SAN DIEGO, CA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.5MFY2023
  2. 1.4MFY2024
  3. 4.1MFY2026

By type

  1. Grants$4.1M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 12.420 · Military Medical Research and Development$1.7M43%
  2. 93.242 · Mental Health Research Grants$1.5M36%
  3. 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders$847.7K21%

Awarding agencies

  1. National Institutes of Health$2.3M57%
    Department of Health and Human Services
  2. Defense Health Agency$1.7M43%
    Department of Defense

Largest awards

  1. IMPLEMENTING A COUPLED SYSTEM OF INTEGRATIVE ML MODELING AND DATA VALIDATION FOR ELUCIDATING MICROGLIAL THERAPEUTIC TARGETS IN…$2.9M
    93.242 · Mental Health Research Grants· National Institutes of Health· Project grant· Sep 15, 2023 – Jan 26, 2026· R44MH135465
  2. THERAPEUTIC DEVELOPMENT OF AN NR1H3-TARGETING ANTISENSE OLIGONUCLEOTIDE FOR ALS$1.7M
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· Apr 21, 2026 – May 19, 2026· HT9425261E084
  3. DEVELOPING AN AI-GUIDED TRICULTURE PLATFORM TO MODEL NEUROHIV SPECIFIC MICROGLIAL STATES UNDER ART SUPPRESSION WITH CELLPAINT/MORPHOLOGICAL…$1.5M
    93.242 · Mental Health Research Grants· National Institutes of Health· Project grant· Feb 25, 2026 – Feb 25, 2026· R61MH143793
  4. THE THERAPEUTIC DEVELOPMENT OF A CLINICAL NR1H3 ANTISENSE OLIGONUCLEOTIDE TO REPROGRAM MICROGLIA INTO A NEUROPROTECTIVE STATE IN ALS AND…$847.7K
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Sep 19, 2026 – Sep 19, 2026· R44NS143633

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 3, 2026, loaded Oct 3, 2026 · Subawards loaded from FY2021.

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2023–FY2026.